Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy

Author(s):
Reza MalekzadehReza Malekzadeh1,*, Hossein PoustchiHossein Poustchi2
1Digestive Disease research Center ,Shariati Hospital, Tehran University of Medical Sciences, [email protected], IR Iran
2Digestive Disease research Center ,Shariati Hospital, Tehran University of Medical Sciences, IR Iran

Hepatitis Monthly:Vol. 11, issue 3; 157-158
Published online:Mar 31, 2011
Article type:Editorial
Received:Mar 06, 2011
Accepted:Mar 12, 2011
How to Cite:Malekzadeh R, Poustchi H. Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy. Hepat Mon. 2011;11(3):. doi:

Abstract

Full Text

Full text is available in PDF

Similar Articles

30
Sep
2011

Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection

Mortada Hassan El-Shabrawi,
Mona Isa

El-Shabrawi M, Isa M. Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.711

31
May
2012

Would the Physicians Eventually Obsolete the Liver Biopsy for the Assessment of Liver Fibrosis?

Hadi Parsian,
Maryam Alizadeh,
Hajar Negahdar

Parsian H, Alizadeh M, Negahdar H. Would the Physicians Eventually Obsolete the Liver Biopsy for the Assessment of Liver Fibrosis?. Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6227

31
May
2012

Two or More Synchronous Combination of Noninvasive Test to Increase Accuracy of Liver Fibrosis in Chronic Hepatitis C

Roberto Testa

Testa R. Two or More Synchronous Combination of Noninvasive Test to Increase Accuracy of Liver Fibrosis in Chronic Hepatitis C. Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6229

20
Jul
2011

Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C

Jose M. Ladero,
Jose M Ladero

Ladero J, Ladero J. Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.738

31
Jul
2011

Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?

Claudia Della Corte,
Anna Alisi,
Valerio Nobili

Della Corte C, Alisi A, Nobili V. Indirect markers of fibrosis in chronic liver diseases: Is aspartate transaminase-to-platelet ratio (APRI) a useful test?. Hepat Mon. 2011;11(7):. doi:

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles